Repair Biotechnologies

Syracuse, NY · Founded 2018 · Privately Held (backing)

Operator of a preclinical biotechnology company intended to develop drugs for cholesterol and aging-related diseases. Repair Biotechnologies is based in Syracuse, NY and was founded in 2018. It was valued at $74.4 million at its seed round in Nov 2025, the last priced event on record. It has raised $22.9 million across 6 recorded rounds; the latest was a $5.3 million early-stage round in Nov 2025.

PMV mark · valuation
$74.4M
Oct 2026
Priced at
its seed round
Nov 2025
Total raised
$22.9M
Last round
Early Stage VC
Nov 2025
What is Repair Biotechnologies worth?
$74.4MPrivateMarketView mark · Oct 2026

Valued at $74.4M at its seed round, Nov 2025. Nothing has traded since.

Free account
More of Repair Biotechnologies with a free account
  • ·The complete investor list: 14 names
  • ·Watch Repair Biotechnologies: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Repair Biotechnologies funding history

6 rounds
DateRoundRaisedPost-money
Nov 2025Early Stage VC$5.3M▮
Mar 2024Early Stage VC$6.2M▮
Jun 2023Early Stage VC$8.4M▮
Aug 2020Seed Round$2.9M▮
Mar 2019Seed Round$2.1M▮
Jul 2018Seed Round$450K▮
Unlock post-money valuations

Membership and data by Private Market View

Repair Biotechnologies valuation

Repair Biotechnologies was valued at $74.4 million at its seed round in Nov 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Repair Biotechnologies raised?

Repair Biotechnologies has raised $22.9 million across 6 recorded rounds since 2018. The largest was an $8.4 million early-stage round in Jun 2023; the most recent was a $5.3 million early-stage round in Nov 2025.

Repair Biotechnologies has filed 8 Form Ds with the SEC since 2018, most recently in Mar 2024 ($6.2 million sold to 7 investors).

How Repair Biotechnologies's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Repair Biotechnologies, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about Repair Biotechnologies

What is Repair Biotechnologies worth?
Repair Biotechnologies is valued at $74.4M as of Oct 2026. Valued at $74.4M at its seed round, Nov 2025. Nothing has traded since.
How much has Repair Biotechnologies raised?
Repair Biotechnologies has raised $22.9M in total funding across 6 recorded rounds.
When did Repair Biotechnologies last raise?
Repair Biotechnologies last raised in Nov 2025 (Early Stage VC), raising $5.3M.